glp 1 ckd Taking the next step: the role of GLP-1RAs in the and T2D nexus Chronic kidney disease in type

Trong cc nguyn bo si tim c nui cy, L-carnitine lm gim s sn sinh collagen do angiotensin II gy ra vi vic tng biu hin FADS1/2 v tng cng sn xut axit arachidonic v prostacyclin

Nov 2009;32 Suppl 2:S157-163

Indian pharmas like Sun Pharma, Lupin eye $1.2B windfall

Res 72 , 603612 (2003)

Weight (kg) and BMI (kg/m 2 ) were recorded prior to initiation and after 1216 weeks of treatment with GLP-1 receptor agonist

189 Recent studies overturned this long-standing dogma by showing that multiple experimental approaches to removing or genetically attenuating the astrocyte borders that form around lesions all failed to result in spontaneous axon regeneration